date,title,source
Oct-24-18,XBiotech Announces Dismissal of Securities Class Action Suit,GlobeNewswire
Oct-31-18,XBiotech Highlights Third Quarter Developments for 2018,GlobeNewswire
Nov-23-18,"Detailed Research: Economic Perspectives on Jason Industries, XBiotech, Dynatronics, Evolving, CTI BioPharma, and Charles & Colvard  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
Dec-03-18,XBiotech Announces Successful Completion of GMP Audit,GlobeNewswire
Dec-12-18,XBiotechs Results from Phase 2 Atopic Dermatitis Study Suggest New Drug to Treat Skin Disease,GlobeNewswire
